Pharmaceutical quality of ceftriaxone generic drug products compared with Rocephin®

被引:35
作者
Lambert, PA [1 ]
Conway, BR [1 ]
机构
[1] Aston Univ, Aston Pharm Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England
关键词
ceftriaxone; Rocephin (R); generics; pharmaceutical quality;
D O I
10.1179/joc.2003.15.4.357
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The pharmaceutical qualities of 34 ceftriaxone generic products were compared with Rocephin(R) as the reference standard. Quality standards specified in the European and US Pharmacopoeias were violated on 18 occasions, including those for sterility (4 products) and impurities (5 products). All 34 generics tested failed to meet Roche specifications for Rocephin(R), with 100 contraventions of the Roche Pharmaceutical standards. The most common failures amongst generic drug products were clarity of solution (30 products) and presence of thiotriazinone (33 products).
引用
收藏
页码:357 / 368
页数:12
相关论文
共 22 条
[1]   PROSPECTIVE COMPARATIVE TRIAL OF CEFTRIAXONE VS CONVENTIONAL THERAPY FOR TREATMENT OF BACTERIAL-MENINGITIS IN CHILDREN [J].
BARSON, WJ ;
MILLER, MA ;
BRADY, MT ;
POWELL, DA .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1985, 4 (04) :362-368
[2]   CEFTRIAXONE - A REAPPRAISAL OF ITS ANTIBACTERIAL ACTIVITY AND PHARMACOKINETIC PROPERTIES, AND AN UPDATE ON ITS THERAPEUTIC USE WITH PARTICULAR REFERENCE TO ONCE-DAILY ADMINISTRATION [J].
BROGDEN, RN ;
WARD, A .
DRUGS, 1988, 35 (06) :604-645
[3]   PLASTIC MATERIAL FROM A SYRINGE CAUSING FATAL BOWEL NECROSIS IN A NEONATE [J].
CANT, AJ ;
LENNEY, W ;
KIRKHAM, N .
BRITISH MEDICAL JOURNAL, 1988, 296 (6627) :968-969
[4]   A survey of the stability of omeprazole products from 13 countries [J].
Davidson, AG ;
McCallum, A .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1996, 22 (12) :1173-1185
[5]  
*EDQM, 2003, EUR PHARM
[6]   MICROPARTICULATE-INDUCED PHLEBITIS - ITS PREVENTION BY IN-LINE FILTRATION [J].
FALCHUK, KH ;
PETERSON, L ;
MCNEIL, BJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (02) :78-82
[7]  
FDA, 1987, GUID VAL LIM AM LYS
[8]  
GIRGIS NI, 1990, DRUG EXP CLIN RES, V16, P607
[9]  
Kirkpatrick C., 1988, KRANKENHAUSPHARMAZIE, V9, P487
[10]  
KIRKPATRICK CJ, 1990, ECC INT, V2, P177